ID   M3K2_HUMAN              Reviewed;         619 AA.
AC   Q9Y2U5; B9EG87; Q53QL9; Q53S75; Q59GZ6; Q8NC32; Q9NYK3;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   12-OCT-2022, entry version 215.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 2;
DE            EC=2.7.11.25;
DE   AltName: Full=MAPK/ERK kinase kinase 2;
DE            Short=MEK kinase 2;
DE            Short=MEKK 2;
GN   Name=MAP3K2; Synonyms=MAPKKK2, MEKK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Su B., Yang J.H., Xia Y., Karin M.;
RT   "MEKK2 is involved in transducing T-cell co-stimulatory signals to the JNK
RT   cascade.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=T-cell;
RA   Wang C., Lo H.;
RT   "Cloning of human MEKK2b cDNA.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 180-619.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH MAP2K7 AND MAPK8.
RX   PubMed=10713157; DOI=10.1128/mcb.20.7.2334-2342.2000;
RA   Cheng J., Yang J., Xia Y., Karin M., Su B.;
RT   "Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK)
RT   kinase 2, and JNK1 results in efficient and specific JNK1 activation.";
RL   Mol. Cell. Biol. 20:2334-2342(2000).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15075238; DOI=10.1242/jcs.01040;
RA   Raviv Z., Kalie E., Seger R.;
RT   "MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated
RT   cells, while MEKK2 translocates from the cytosol to the nucleus upon
RT   stimulation.";
RL   J. Cell Sci. 117:1773-1784(2004).
RN   [10]
RP   FUNCTION.
RX   PubMed=16001074; DOI=10.1038/nature03866;
RA   Pelkmans L., Zerial M.;
RT   "Kinase-regulated quantal assemblies and kiss-and-run recycling of
RT   caveolae.";
RL   Nature 436:128-133(2005).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   UBIQUITINATION BY XIAP/BIRC4, AND INTERACTION WITH XIAP/BIRC4.
RX   PubMed=18761086; DOI=10.1016/j.cellsig.2008.08.004;
RA   Winsauer G., Resch U., Hofer-Warbinek R., Schichl Y.M., de Martin R.;
RT   "XIAP regulates bi-phasic NF-kappaB induction involving physical
RT   interaction and ubiquitination of MEKK2.";
RL   Cell. Signal. 20:2107-2112(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-297, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153; SER-331 AND SER-344, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   INTERACTION WITH STK38, AND SELF-ASSOCIATION.
RX   PubMed=17906693; DOI=10.1038/sj.onc.1210828;
RA   Enomoto A., Kido N., Ito M., Morita A., Matsumoto Y., Takamatsu N.,
RA   Hosoi Y., Miyagawa K.;
RT   "Negative regulation of MEKK1/2 signaling by serine-threonine kinase 38
RT   (STK38).";
RL   Oncogene 27:1930-1938(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153; SER-159 AND SER-164, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26; SER-153; SER-331 AND
RP   SER-344, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; SER-331 AND SER-344, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153; SER-239; SER-311 AND
RP   SER-331, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-331, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   STRUCTURE BY NMR OF 43-132.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the PB1 domain of human protein kinase MEKK2B.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [25]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-110; ILE-112 AND GLY-140.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Component of a protein kinase signal transduction cascade.
CC       Regulates the JNK and ERK5 pathways by phosphorylating and activating
CC       MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-
CC       run dynamics. {ECO:0000250, ECO:0000269|PubMed:10713157,
CC       ECO:0000269|PubMed:16001074}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.25;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.25;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation on Thr-524.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with PKN2; the interaction activates PKN2 kinase
CC       activity in a MAP3K2-independent kinase activity (By similarity). Self-
CC       associates. Binds both upstream activators and downstream substrates in
CC       multimolecular complexes. Interacts (via the kinase catalytic domain)
CC       with STK38. Interacts with XIAP/BIRC4. {ECO:0000250,
CC       ECO:0000269|PubMed:10713157, ECO:0000269|PubMed:17906693,
CC       ECO:0000269|PubMed:18761086}.
CC   -!- INTERACTION:
CC       Q9Y2U5; Q13163: MAP2K5; NbExp=6; IntAct=EBI-357393, EBI-307294;
CC       Q9Y2U5; P31947: SFN; NbExp=2; IntAct=EBI-357393, EBI-476295;
CC       Q9Y2U5; Q9H7B4-1: SMYD3; NbExp=3; IntAct=EBI-357393, EBI-16204880;
CC       Q9Y2U5; Q9UNE7: STUB1; NbExp=9; IntAct=EBI-357393, EBI-357085;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15075238}. Nucleus
CC       {ECO:0000269|PubMed:15075238}. Note=Upon EGF stimulation, translocates
CC       into the nucleus.
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- PTM: Ubiquitination by XIAP/BIRC4 does not lead to proteasomal
CC       degradation. {ECO:0000269|PubMed:18761086}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11348.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF111105; AAD28547.1; -; mRNA.
DR   EMBL; AF239798; AAF63496.1; -; mRNA.
DR   EMBL; AB208963; BAD92200.1; -; mRNA.
DR   EMBL; AC068282; AAY15043.1; -; Genomic_DNA.
DR   EMBL; AC110926; AAY15070.1; -; Genomic_DNA.
DR   EMBL; CH471103; EAW95315.1; -; Genomic_DNA.
DR   EMBL; BC136293; AAI36294.1; -; mRNA.
DR   EMBL; AK075004; BAC11348.1; ALT_INIT; mRNA.
DR   CCDS; CCDS46404.1; -.
DR   RefSeq; NP_006600.3; NM_006609.4.
DR   PDB; 2CU1; NMR; -; A=43-132.
DR   PDB; 2NPT; X-ray; 1.75 A; B/D=26-123.
DR   PDB; 5EX0; X-ray; 2.70 A; D=256-265.
DR   PDB; 5HQ8; X-ray; 1.72 A; I/J=250-264.
DR   PDB; 6LDV; X-ray; 1.90 A; P=252-265.
DR   PDB; 6LDW; X-ray; 1.60 A; C/D=252-265.
DR   PDB; 6LDX; X-ray; 1.80 A; B=252-265.
DR   PDB; 6LDY; X-ray; 1.77 A; C/M=252-265.
DR   PDBsum; 2CU1; -.
DR   PDBsum; 2NPT; -.
DR   PDBsum; 5EX0; -.
DR   PDBsum; 5HQ8; -.
DR   PDBsum; 6LDV; -.
DR   PDBsum; 6LDW; -.
DR   PDBsum; 6LDX; -.
DR   PDBsum; 6LDY; -.
DR   AlphaFoldDB; Q9Y2U5; -.
DR   SMR; Q9Y2U5; -.
DR   BioGRID; 115969; 48.
DR   CORUM; Q9Y2U5; -.
DR   DIP; DIP-39756N; -.
DR   IntAct; Q9Y2U5; 35.
DR   MINT; Q9Y2U5; -.
DR   STRING; 9606.ENSP00000387246; -.
DR   BindingDB; Q9Y2U5; -.
DR   ChEMBL; CHEMBL5914; -.
DR   DrugBank; DB06616; Bosutinib.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9Y2U5; -.
DR   GuidetoPHARMACOLOGY; 2077; -.
DR   iPTMnet; Q9Y2U5; -.
DR   MetOSite; Q9Y2U5; -.
DR   PhosphoSitePlus; Q9Y2U5; -.
DR   BioMuta; MAP3K2; -.
DR   DMDM; 97536681; -.
DR   CPTAC; CPTAC-843; -.
DR   CPTAC; CPTAC-844; -.
DR   EPD; Q9Y2U5; -.
DR   jPOST; Q9Y2U5; -.
DR   MassIVE; Q9Y2U5; -.
DR   MaxQB; Q9Y2U5; -.
DR   PaxDb; Q9Y2U5; -.
DR   PeptideAtlas; Q9Y2U5; -.
DR   PRIDE; Q9Y2U5; -.
DR   ProteomicsDB; 85903; -.
DR   ABCD; Q9Y2U5; 4 sequenced antibodies.
DR   Antibodypedia; 33427; 278 antibodies from 36 providers.
DR   DNASU; 10746; -.
DR   Ensembl; ENST00000344908.9; ENSP00000343463.5; ENSG00000169967.17.
DR   Ensembl; ENST00000409947.5; ENSP00000387246.1; ENSG00000169967.17.
DR   Ensembl; ENST00000682094.1; ENSP00000507315.1; ENSG00000169967.17.
DR   GeneID; 10746; -.
DR   KEGG; hsa:10746; -.
DR   MANE-Select; ENST00000682094.1; ENSP00000507315.1; NM_001371910.2; NP_001358839.1.
DR   UCSC; uc002toj.3; human.
DR   CTD; 10746; -.
DR   DisGeNET; 10746; -.
DR   GeneCards; MAP3K2; -.
DR   HGNC; HGNC:6854; MAP3K2.
DR   HPA; ENSG00000169967; Low tissue specificity.
DR   MIM; 609487; gene.
DR   neXtProt; NX_Q9Y2U5; -.
DR   OpenTargets; ENSG00000169967; -.
DR   PharmGKB; PA30598; -.
DR   VEuPathDB; HostDB:ENSG00000169967; -.
DR   eggNOG; KOG0198; Eukaryota.
DR   GeneTree; ENSGT00940000156884; -.
DR   HOGENOM; CLU_029447_0_0_1; -.
DR   InParanoid; Q9Y2U5; -.
DR   OMA; VFTPEYE; -.
DR   OrthoDB; 55144at2759; -.
DR   PhylomeDB; Q9Y2U5; -.
DR   TreeFam; TF105113; -.
DR   BRENDA; 2.7.12.2; 2681.
DR   PathwayCommons; Q9Y2U5; -.
DR   SignaLink; Q9Y2U5; -.
DR   SIGNOR; Q9Y2U5; -.
DR   BioGRID-ORCS; 10746; 25 hits in 1110 CRISPR screens.
DR   ChiTaRS; MAP3K2; human.
DR   EvolutionaryTrace; Q9Y2U5; -.
DR   GeneWiki; MAP3K2; -.
DR   GenomeRNAi; 10746; -.
DR   Pharos; Q9Y2U5; Tchem.
DR   PRO; PR:Q9Y2U5; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9Y2U5; protein.
DR   Bgee; ENSG00000169967; Expressed in jejunal mucosa and 193 other tissues.
DR   ExpressionAtlas; Q9Y2U5; baseline and differential.
DR   Genevisible; Q9Y2U5; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:MGI.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:Ensembl.
DR   CDD; cd06405; PB1_Mekk2_3; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR034879; PB1_MEKK2/3.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00564; PB1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00666; PB1; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51745; PB1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cytoplasm; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN           1..619
FT                   /note="Mitogen-activated protein kinase kinase kinase 2"
FT                   /id="PRO_0000086243"
FT   DOMAIN          43..122
FT                   /note="PB1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01081"
FT   DOMAIN          357..617
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          25..45
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          154..173
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          201..248
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          289..355
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        201..221
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        289..319
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        337..351
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        483
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         362..371
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         385
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         153
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         164
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         239
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         297
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336"
FT   MOD_RES         311
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         331
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         344
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:19690332"
FT   MOD_RES         349
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61083"
FT   VARIANT         110
FT                   /note="I -> V (in dbSNP:rs55767983)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040682"
FT   VARIANT         112
FT                   /note="M -> I (in a lung large cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040683"
FT   VARIANT         140
FT                   /note="D -> G (in dbSNP:rs56307783)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040684"
FT   CONFLICT        1
FT                   /note="M -> GTR (in Ref. 3; BAD92200)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        103
FT                   /note="V -> L (in Ref. 1; AAD28547 and 2; AAF63496)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        198
FT                   /note="D -> E (in Ref. 1; AAD28547 and 2; AAF63496)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        225
FT                   /note="D -> G (in Ref. 1; AAD28547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        275..277
FT                   /note="QEY -> KD (in Ref. 1; AAD28547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        293..296
FT                   /note="TSLR -> NQLT (in Ref. 1; AAD28547 and 2; AAF63496)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        413
FT                   /note="L -> F (in Ref. 1; AAD28547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        459
FT                   /note="V -> G (in Ref. 1; AAD28547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        480
FT                   /note="V -> L (in Ref. 1; AAD28547)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        536
FT                   /note="E -> Q (in Ref. 1; AAD28547 and 2; AAF63496)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        579
FT                   /note="N -> S (in Ref. 7; BAC11348)"
FT                   /evidence="ECO:0000305"
FT   STRAND          44..50
FT                   /evidence="ECO:0007829|PDB:2NPT"
FT   STRAND          53..59
FT                   /evidence="ECO:0007829|PDB:2NPT"
FT   HELIX           65..76
FT                   /evidence="ECO:0007829|PDB:2NPT"
FT   STRAND          80..86
FT                   /evidence="ECO:0007829|PDB:2NPT"
FT   STRAND          89..92
FT                   /evidence="ECO:0007829|PDB:2NPT"
FT   HELIX           96..108
FT                   /evidence="ECO:0007829|PDB:2NPT"
FT   STRAND          114..121
FT                   /evidence="ECO:0007829|PDB:2NPT"
FT   STRAND          260..262
FT                   /evidence="ECO:0007829|PDB:5EX0"
SQ   SEQUENCE   619 AA;  69741 MW;  E034580D349F097F CRC64;
     MDDQQALNSI MQDLAVLHKA SRPALSLQET RKAKSSSPKK QNDVRVKFEH RGEKRILQFP
     RPVKLEDLRS KAKIAFGQSM DLHYTNNELV IPLTTQDDLD KAVELLDRSI HMKSLKILLV
     INGSTQATNL EPLPSLEDLD NTVFGAERKK RLSIIGPTSR DRSSPPPGYI PDELHQVARN
     GSFTSINSEG EFIPESMDQM LDPLSLSSPE NSGSGSCPSL DSPLDGESYP KSRMPRAQSY
     PDNHQEFSDY DNPIFEKFGK GGTYPRRYHV SYHHQEYNDG RKTFPRARRT QGTSLRSPVS
     FSPTDHSLST SSGSSIFTPE YDDSRIRRRG SDIDNPTLTV MDISPPSRSP RAPTNWRLGK
     LLGQGAFGRV YLCYDVDTGR ELAVKQVQFD PDSPETSKEV NALECEIQLL KNLLHERIVQ
     YYGCLRDPQE KTLSIFMEYM PGGSIKDQLK AYGALTENVT RKYTRQILEG VHYLHSNMIV
     HRDIKGANIL RDSTGNVKLG DFGASKRLQT ICLSGTGMKS VTGTPYWMSP EVISGEGYGR
     KADIWSVACT VVEMLTEKPP WAEFEAMAAI FKIATQPTNP KLPPHVSDYT RDFLKRIFVE
     AKLRPSADEL LRHMFVHYH
//
